For Immediate Release
Rockville, MD. (June 4, 2018) – Verax Research Services, Inc. (Verax ResearchTM) introduces the most advanced research and infrastructure services to support and streamline cannabis enterprise. Verax Research has secured investment and infrastructure Intellectual Property licenses from three companies to facilitate, compile and integrate the most advanced service offering available globally for Verax Research Service’s healthcare product manufacturer clients developing hemp-related products.
As part of its recent acquisitions, Verax Research has received the exclusive license for CannacopeiaTM, a comprehensive database of cannabinoids and other phyto-nutrients derived from cannabis plants as well as evidence-based data and research from Vitreon AmericaTM, Inc., which has the BotanicopeiaTM database of 8,000 plants and 40,000 plant constituents first developed by James A. Duke, PhD, founder of Green Farmacy Garden® and Botanica ElaborumTM. The Botanicopeia database has twice as many plants and four times the plant constituents registered in the United State Department of Agriculture (USDA) database, which Dr. Duke also spearheaded the development for the USDA. From the Botanicopeia database, the Cannocopeia extracted the Cannabinoids database and Verax Research has created over 100 unique evidence-based research reports from this database which can be utilized to advance Verax Research’s Product Development and Manufacturer Clients research.
Verax Research has received a license to the Product Safety Assurance Services Inc. proprietary protocols and systems for testing, validating and certifying pharmaceutical raw materials and finished products for the pharmaceutical manufacturer industry. Verax Research has modified the Product Safety Assurance Services protocols and system for the specific U.S. and other Globally Harmonized Government Agencies requirements to insure the raw material and finished product supply chain security and integrity. Over the last twenty years, 15 of the Top 30 Pharmaceutical Companies have utilized Product Safety Assurance Services for these critical product development and manufacturing requirements to insure the products’ safety for their patients.
To complete the additional transmission and secure transactions auditing of Hemp constituent ingredient purchases from raw materials to finished products, Verax Research licensed Advasur, LLC product raw materials and finished product pedigree and product auditing systems. Verax Research Services now has the most advanced and industry proven infrastructure capabilities to assist its healthcare product development and manufacturing clients develop innovative hemp constituent containing products.
About Verax Research Services, Inc.
Verax Research Services, Inc., founded in June 2017 as a Delaware C-Corporation by proven and trusted Pharmaceutical and Medical Device Executives with a singular objective: Ensure Hemp Research and Product Development Leads to Safe and Effective Healthcare Products. To accomplish this objective, Verax Research provides research, product development and raw material testing, as well as, validation and certification of Hemp constituent raw materials for Verax Research’s pharmaceutical and other healthcare manufacturer clients. Located at Johns Hopkins University, Verax Research has developed the infrastructure to support our clients and to meet their hemp constituent needs. For more information, visit www.veraxresearch.com.
